- Published at
- by investing.com
positive
positive
Physiomics obtains trial approval for cancer dosing software By Investing.com
Physiomics obtains trial approval for cancer dosing software
News for Physiomics Plc (PYC.L)
- Published at
- by marketscreener.com
positivepositiveEARNINGS AND TRADING: Sound Energy sells part of Moroccan assets
The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: ---------- Sound Energy PLC - Moroccan-focused...- Published at
- by marketscreener.com
positivepositivePhysiomics inks contract with old client worth GBP186,000
Physiomics PLC - Abingdon, Oxfordshire-based mathematical modelling and data science for new medicines - Wins new contract from an existing, large client, worth GBP186,000. According to the...- Published at
- by marketscreener.com
mixedmixedEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech
The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday this week and not separately reported by Alliance News: ---------- Pinewood...- Published at
- by marketscreener.com
neutralneutralPhysiomics shares drop as annual loss widens; revenue falls
Physiomics PLC on Thursday kept its outlook upbeat, despite reporting a drop in revenue in what it called a difficult year. Physiomics is a mathematical modelling company that supports oncology drug...- Published at
- by marketscreener.com
mixedmixedAIM WINNERS & LOSERS: Bradda shares surge on updated resource estimate -September 28, 2023 at 05:46 am EDT
The following stocks are the leading risers and fallers on AIM in London on Thursday. ---------- AIM - WINNERS ---------- Bradda Head Lithium Ltd, up 24% at 3.40 pence, 12-month range 2.70-9.54p. The...- Published at
- by marketscreener.com
positivepositivePhysiomics brings in chief operating officer; shares soar
Physiomics PLC on Monday named Peter Sargent as its new chief operating officer. Shares in Physiomics were up 21% at 1.90 pence each in London on Monday morning. The mathematical modelling company...- Published at
- by marketscreener.com
positivepositivePhysiomics wins new deal following Merck contract extension
Physiomics PLC on Thursday said it won its first contract with an unnamed UK-based biotech client. The London-based mathematical modelling company that supports oncology drug development said the...- Published at
- by globenewswire.com
neutralneutralBiosimulation Market to Reach $10.6 Billion, Globally, by 2032 at 15.8% CAGR: Allied Market Research
The rise in the prevalence of chronic diseases such as cancer, diabetes, Alzheimer's, cardiovascular disease, and kidney disorders, the increase in demand...- Published at
- by prnewswire.com
mixedmixedThe Biosimulation Market size to grow at a CAGR of 15.06% from 2022 to 2027 | An increase in research funding and grants to boost market growth - Technavio
/PRNewswire/ -- The biosimulation market is to grow by USD 3,163.61 million from 2022 to 2027 and register a CAGR of 15.06%, according to Technavio's latest...- Published at
- by marketscreener.com
mixedmixedGalantas Gold closes placement; Kropz makes draw down
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Kropz PLC - South Africa-focused phosphate producer and... | March 28, 2023